V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10466578 | 10057723 | 1.64 | 83 | Curative (C) | null | 2018-05-14 | MaxiCHOP (>Cycle 2) | 02 | N | ISATUXIMAB + POMALIDOMIDE | 100674194 |
| 10466639 | 10057724 | 1.68 | 62.5 | Palliative (P) | 2022-04-29 | 2022-05-05 | null | 02 | N | DOXORUBICIN EMBOLISATION | 101407848 |
| 10466700 | 10057725 | 1.62 | 70.8 | null | 2018-11-15 | 2018-11-15 | ABEMACICLIB + FULVESTRANT | 02 | null | OBINUTUZUMAB | 101345294 |
| 10466767 | 10057726 | 1.63 | 93.7 | Palliative (P) | 2021-04-16 | 2021-05-12 | BCG Intravesical | 02 | N | DASATINIB | 101582196 |
| 10466858 | 10057727 | 1.58 | 70.4 | null | 2015-12-24 | 2015-12-28 | Lomustine | 02 | null | IRINOTECAN | 101035522 |
| 10466860 | 10057728 | 1.82 | 73 | null | 2017-06-13 | 2017-06-15 | CARFILZOMIB | 02 | null | BUSULPHAN | 100865503 |
| 10466999 | 10057731 | null | null | null | 2017-10-26 | 2017-10-26 | LENALIDOMIDE + RITUXIMAB | N | null | DOXORUBICIN EMBOLISATION | 101180229 |
| 10467071 | 10057732 | 1.8 | 69 | null | 2020-09-02 | 2021-12-19 | LEAM | 02 | N | MERCAPTOPURINE | 101507302 |
| 10467132 | 10057733 | 1.65 | 81.8 | null | 2015-04-29 | 2019-08-19 | Docetaxel + nintedanib | 02 | null | ISATUXIMAB + POMALIDOMIDE | 100879248 |
| 10467140 | 10057734 | 1.69 | 75.6 | null | 2017-09-15 | 2017-10-05 | Bexarotene | 02 | null | OBINUTUZUMAB | 100096909 |
| 10467170 | 10057735 | 1.69 | 80.6 | Palliative (P) | 2021-10-07 | 2022-05-09 | Durvalumab | 02 | N | TRANSPLANT CARMUSTINE + THIOTEPA | 101001705 |
| 10467175 | 10057736 | 1.61 | 75 | null | 2019-01-02 | 2019-01-16 | LENALIDOMIDE + RITUXIMAB | 02 | null | PARTNER TRIAL | 101641637 |
| 10467214 | 10057737 | 1.68 | 77.2 | Palliative (P) | 2018-06-16 | 2018-07-10 | Dasatinib | 02 | N | TRAMETINIB | 101200479 |
| 10467290 | 10057738 | 1.7 | 55.6 | null | 2016-09-20 | 2016-09-20 | ANAGRELIDE | 02 | null | DOCETAXEL + TRASTUZUMAB | 101496437 |
| 10467358 | 10057739 | 1.89 | 86 | Curative (C) | 2018-07-03 | 2019-04-03 | ELOQUENT 2 trial | 02 | N | FLUOROURACIL + MITOMYCIN | 100450584 |
| 10467370 | 10057740 | 1.82 | 53.7 | Curative (C) | 2019-08-12 | 2019-09-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | NILOTINIB | 101407421 |
| 10467889 | 10057744 | 1.77 | 59.3 | Palliative (P) | 2018-04-17 | 2018-11-19 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100507259 |
| 10467904 | 10057745 | 1.64 | 62.6 | null | 2019-06-15 | 2019-06-25 | Erlotinib | 02 | null | EPIRUBICIN | 101058072 |
| 10468004 | 10057746 | 1.67 | 67 | null | null | 2021-11-14 | null | 02 | null | MITOMYCIN | 101096281 |
| 10468198 | 10057747 | 1.81 | 74.3 | Palliative (P) | 2019-01-06 | 2019-02-13 | TRANSPLANT CYCLOPHOSPHAMIDE + FLUDARABINE (+/- TBI) | 02 | N | GEMCITABINE + PACLITAXEL | 100547929 |
| 10468234 | 10057748 | 1.7 | 61.6 | Curative (C) | 2019-12-06 | 2020-01-04 | ANAGRELIDE | 01 | null | ABEMACICLIB + FULVESTRANT | 100891207 |
| 10468465 | 10057750 | 1.84 | 76.6 | Palliative (P) | 2018-10-22 | 2018-12-18 | Eribulin | null | N | LENALIDOMIDE + RITUXIMAB | 101175957 |
| 10468511 | 10057751 | 1.61 | 73.4 | null | 2017-04-02 | 2017-08-21 | Alemtuz+Fludara+Melphalan RIC MUD | 99 | null | PACLITAXEL + TRASTUZUMAB | 101838528 |
| 10468761 | 10057752 | 1.73 | 78.7 | Palliative (P) | 2018-06-01 | 2018-06-01 | Brentuximab Vedotin | 02 | N | DOXORUBICIN + OLARATUMAB | 100421318 |
| 10468832 | 10057753 | 0 | 78.5 | null | 2018-08-02 | 2018-08-02 | Mitomycin Intravesical | 02 | null | CYTARABINE + DAUNORUBICIN | 101693728 |
| 10468857 | 10057754 | 0 | 72.4 | Palliative (P) | 2019-12-12 | 2019-12-25 | Nilotinib | N | N | BEVACIZUMAB + OLAPARIB | 101815249 |
| 10468903 | 10057755 | 1.7 | 63.8 | Palliative (P) | 2018-03-14 | 2018-04-19 | null | 99 | N | CYCLOPHOSPHAMIDE + OBINUTUZUMAB + VINCRISTINE | 100130966 |
| 10468917 | 10057756 | 1.7 | 85 | Palliative (P) | 2018-11-07 | 2018-11-08 | Cetuximab + Encorafenib | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101316497 |
| 10468967 | 10057757 | 1.73 | 83.7 | null | 2018-10-19 | 2018-10-28 | EVEROLIMUS + EXEMESTANE | 02 | null | LOMUSTINE + PROCARBAZINE | 100902118 |
| 10469277 | 10057758 | 1.67 | 58.4 | null | 2019-10-30 | 2019-11-04 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | TRASTUZUMAB DERUXTECAN | 100900403 |
| 10469283 | 10057759 | 1.68 | 58.7 | null | 2019-07-14 | 2019-07-14 | Folfirinox | 02 | null | DOCETAXEL + NINTEDANIB | 101105625 |
| 10469564 | 10057761 | 1.68 | 56 | Palliative (P) | 2020-10-03 | 2020-10-03 | FIGARO TRIAL | N | N | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 100168725 |
| 10469587 | 10057762 | 1.65 | 89.7 | Palliative (P) | 2017-02-16 | 2017-09-10 | CHLORAMBUCIL + RITUXIMAB | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100853661 |
| 10469694 | 10057763 | 1.68 | 74.2 | null | 2018-04-02 | 2018-07-01 | IDELALISIB + RITUXIMAB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101595280 |
| 10469699 | 10057764 | null | null | null | 2020-10-28 | 2020-12-04 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | FLUOROURACIL + MITOMYCIN | 101325936 |
| 10469800 | 10057765 | 1.69 | 69.5 | Palliative (P) | 2019-10-06 | 2019-10-14 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB | 100844177 |
| 10470026 | 10057766 | 1.67 | 83.35 | Curative (C) | 2019-08-07 | 2019-08-13 | null | 02 | N | TRANSPLANT CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100238493 |
| 10470847 | 10057773 | null | null | Palliative (P) | 2017-07-31 | 2017-08-11 | Cyclophos + Dex + Lenalidomide | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100737037 |
| 10470868 | 10057774 | 1.86 | 67.7 | null | 2021-01-23 | 2021-01-31 | AVAPRITINIB | 02 | null | TRIAL | 100394845 |
| 10470896 | 10057776 | 1.77 | 80.65 | null | 2021-04-18 | 2021-04-22 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | null | IXAZOMIB | 101400672 |
| 10470945 | 10057777 | 1.67 | 107 | Palliative (P) | 2022-01-16 | 2022-01-16 | Alemtuzumab(INTRAVENOUS) | 01 | N | DOXORUBICIN + OLARATUMAB | 100242037 |
| 10471432 | 10057781 | null | null | 03 | 2019-10-18 | 2019-10-31 | Nintedanib | N | N | DURVALUMAB | 101558510 |
| 10471444 | 10057782 | 1.7 | 68.95 | 03 | 2018-03-25 | 2018-04-05 | ANAGRELIDE | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100542037 |
| 10471450 | 10057783 | 1.81 | 55.6 | 03 | 2019-08-16 | 2019-08-16 | STAMPEDE TRIAL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101149408 |
| 10471485 | 10057784 | 0 | 84 | Disease modification (D) | 2020-11-23 | 2022-04-19 | BCG Intravesical | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100395654 |
| 10472188 | 10057789 | 1.55 | 79.5 | Curative (C) | 2017-03-29 | 2017-11-11 | CARFILZOMIB | 02 | N | ETOPOSIDE | 101541824 |
| 10472359 | 10057790 | null | 76.8 | Palliative (P) | 2016-02-24 | 2016-09-02 | Binimetinib + Encorafenib | 02 | N | BINIMETINIB + ENCORAFENIB | 100846632 |
| 10472514 | 10057791 | null | 70 | null | 2018-04-23 | 2018-04-24 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 02 | null | ZANUBRUTINIB | 101726667 |
| 10472643 | 10057794 | 1.82 | null | Palliative (P) | 2020-11-18 | 2020-11-18 | Sunitinib | 02 | N | TRIAL | 100471881 |
| 10472673 | 10057795 | 1.82 | 80 | Neo-adjuvant (N) | 2020-07-31 | 2020-08-09 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101243986 |